OTC Markets OTCQB - Delayed Quote USD
Escalon Medical Corp. (ESMC)
0.3500
+0.0160
+(4.79%)
At close: May 16 at 4:00:00 PM EDT
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
12,169.1740
11,981.5090
12,180.2210
10,703.0700
10,471.6170
Cost of Revenue
6,793.4050
6,835.3170
6,698.8580
6,096.1690
6,044.3990
Gross Profit
5,375.7690
5,146.1920
5,481.3630
4,606.9010
4,427.2180
Operating Expense
5,165.1250
5,250.6680
5,002.8200
5,076.9640
4,460.9150
Operating Income
210.6440
-104.4760
478.5430
-470.0630
-33.6970
Net Non Operating Interest Income Expense
-19.5830
-20.7850
-21.7170
-18.1610
-20.8560
Other Income Expense
--
--
--
506.3050
2.5300
Pretax Income
186.0610
-125.2610
456.8260
18.0810
-52.0230
Tax Provision
0
0
0
0
--
Net Income Common Stockholders
45.5260
-176.9330
221.5310
-33.5190
-103.4450
Diluted NI Available to Com Stockholders
45.5260
-176.9330
221.5310
-33.5190
-103.4450
Basic EPS
0.01
-0.02
0.03
-0.00
-0.01
Diluted EPS
0.01
-0.02
0.03
-0.00
-0.01
Basic Average Shares
7,415.3290
7,415.3290
7,415.3290
7,415.3290
7,415.3290
Diluted Average Shares
10,748.4720
7,415.3290
13,564.2020
13,220.2020
7,415.3290
Total Operating Income as Reported
210.6440
-104.4760
478.5430
-470.0630
-33.6970
Total Expenses
11,958.5300
12,085.9850
11,701.6780
11,173.1330
10,505.3140
Net Income from Continuing & Discontinued Operation
186.0610
-125.2610
456.8260
18.0810
-52.0230
Normalized Income
186.0610
-125.2610
456.8260
18.0810
-52.0230
Interest Income
--
--
0.1280
0.2450
0.9850
Interest Expense
19.5830
20.7850
21.7170
18.4060
21.8410
Net Interest Income
-19.5830
-20.7850
-21.7170
-18.1610
-20.8560
EBIT
205.6440
-104.4760
478.5430
36.4870
-30.1820
EBITDA
248.9580
-58.4610
523.7450
84.9190
14.6300
Reconciled Cost of Revenue
6,793.4050
6,835.3170
6,698.8580
6,096.1690
6,044.3990
Reconciled Depreciation
43.3140
46.0150
45.2020
48.4320
44.8120
Net Income from Continuing Operation Net Minority Interest
186.0610
-125.2610
456.8260
18.0810
-52.0230
Total Unusual Items Excluding Goodwill
--
--
--
--
0
Total Unusual Items
--
--
--
--
0
Normalized EBITDA
248.9580
-58.4610
523.7450
84.9190
14.6300
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
6/30/2021 - 9/11/1992
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CSDX CS Diagnostics Corp.
0.0800
-11.11%
FA0.F PExA AB (publ)
0.0150
+11.11%
A2P.F Synektik Spólka Akcyjna
52.80
-2.13%
LT3.F Axogen, Inc.
10.50
+1.94%
EPIS-B.ST Episurf Medical AB (publ)
0.1098
-2.49%
NEOLA.ST Neola Medical AB (publ)
2.4100
0.00%
PETVW PetVivo Holdings, Inc.
0.0992
+248.07%
CGHC Capital Group Holdings, Inc.
0.0002
0.00%
SYK.BE Stryker Corp
348.10
+1.31%
IHC.L Inspiration Healthcare Group plc
19.70
+9.44%